1h Free Analyst Time
The digital therapeutics market is forecasted to grow by USD 19.17 billion during 2023-2028, accelerating at a CAGR of 32.59% during the forecast period. The report on the digital therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, advancements in technology in digital therapeutics, and growing adoption of smartphones and connected devices.
The digital therapeutics market is segmented as below:
By Product
- Software
- Devices
By End-user
- Business-to-Consumer
- Business-to-Business
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the digital therapeutics market covers the following areas:
- Digital therapeutics market sizing
- Digital therapeutics market forecast
- Digital therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global digital therapeutics market: 2Morrow Inc., Akili Inc., Alphabet Inc., Better Therapeutics Inc., BigHealth , Brain+ ApS, Canary Health, Click Therapeutics Inc, DarioHealth Corp., Digital Therapeutics Alliance Inc. , GAIA AG, Jogo Health Inc., Limbix Health Inc., Medtronic PLC, Noom Inc., Omada Health Inc., Pear Therapeutics Inc., ResMed Inc., Teladoc Health Inc., and WellDoc Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising adoption of personalized and adaptive interventions."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2Morrow Inc.
- Akili Inc.
- Alphabet Inc.
- Better Therapeutics Inc.
- BigHealth
- Brain+ ApS
- Canary Health
- Click Therapeutics Inc
- DarioHealth Corp.
- Digital Therapeutics Alliance Inc.
- GAIA AG
- Jogo Health Inc.
- Limbix Health Inc.
- Medtronic PLC
- Noom Inc.
- Omada Health Inc.
- Pear Therapeutics Inc.
- ResMed Inc.
- Teladoc Health Inc.
- WellDoc Inc.
